[{"address1": "333 Las Olas Way", "address2": "CU4 Suite 433", "city": "Fort Lauderdale", "state": "FL", "zip": "33301", "country": "United States", "phone": "(954) 330-0684", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 72, "title": "Chairman, President & CEO", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 1291587, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 65, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 352031, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 366625, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 39, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michel  Roy", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 62, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.39, "open": 1.41, "dayLow": 1.3, "dayHigh": 1.41, "regularMarketPreviousClose": 1.39, "regularMarketOpen": 1.41, "regularMarketDayLow": 1.3, "regularMarketDayHigh": 1.41, "payoutRatio": 0.0, "beta": 0.728, "trailingPE": 0.26177025, "forwardPE": 0.006956957, "volume": 119282, "regularMarketVolume": 119282, "averageVolume": 748095, "averageVolume10days": 116000, "averageDailyVolume10Day": 116000, "bid": 1.01, "ask": 1.74, "bidSize": 2, "askSize": 2, "marketCap": 6819263, "fiftyTwoWeekLow": 1.169, "fiftyTwoWeekHigh": 3.9, "allTimeHigh": 19740.0, "allTimeLow": 1.169, "priceToSalesTrailing12Months": 0.18270576, "fiftyDayAverage": 1.6643, "twoHundredDayAverage": 1.661595, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1619413, "profitMargins": -0.16056, "floatShares": 4903934, "sharesOutstanding": 4905945, "sharesShort": 921174, "sharesShortPriorMonth": 208639, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1878, "heldPercentInsiders": 0.00041, "heldPercentInstitutions": 0.07514, "shortRatio": 0.5, "shortPercentOfFloat": 0.1878, "impliedSharesOutstanding": 4905945, "bookValue": 5.309, "priceToBook": 0.26181954, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -5992637, "trailingEps": 5.31, "forwardEps": 199.8, "lastSplitFactor": "1:20", "lastSplitDate": 1723075200, "enterpriseToRevenue": -0.043, "enterpriseToEbitda": 0.355, "52WeekChange": -0.4303279, "SandP52WeekChange": 0.1028198, "quoteType": "EQUITY", "currentPrice": 1.39, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 9306438, "totalCashPerShare": 1.897, "ebitda": -4559393, "totalDebt": 854761, "quickRatio": 2.024, "currentRatio": 4.205, "totalRevenue": 37323744, "debtToEquity": 3.532, "revenuePerShare": 10.72, "returnOnAssets": -0.09867, "returnOnEquity": -0.24340999, "grossProfits": 12319881, "freeCashflow": -6501533, "operatingCashflow": -7126728, "revenueGrowth": 0.116, "grossMargins": 0.33008, "ebitdaMargins": -0.122159995, "operatingMargins": -0.05649, "financialCurrency": "USD", "symbol": "SBFM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "firstTradeDateMilliseconds": 1644935400000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.39, "postMarketChange": 0.0, "regularMarketChange": 0.0, "regularMarketDayRange": "1.3 - 1.41", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 748095, "fiftyTwoWeekLowChange": 0.22099996, "fiftyTwoWeekLowChangePercent": 0.18905042, "fiftyTwoWeekRange": "1.169 - 3.9", "fiftyTwoWeekHighChange": -2.5100002, "fiftyTwoWeekHighChangePercent": -0.6435898, "fiftyTwoWeekChangePercent": -43.03279, "dividendDate": 1586131200, "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 5.31, "epsForward": 199.8, "marketState": "CLOSED", "shortName": "Sunshine Biopharma Inc.", "hasPrePostMarketData": true, "fiftyDayAverageChange": -0.27429998, "fiftyDayAverageChangePercent": -0.16481403, "twoHundredDayAverageChange": -0.271595, "twoHundredDayAverageChangePercent": -0.1634544, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-15", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.39, "longName": "Sunshine Biopharma, Inc.", "corporateActions": [], "postMarketTime": 1763759404, "regularMarketTime": 1763758801, "exchange": "NCM", "messageBoardId": "finmb_78729055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Sunshine Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]